Android app Apple app link

UroGen Pharma Ltd. (URGN) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$19.16
Day's range
$21.06

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
11/05/2026 Oppenheimer Leland Gershell $60.00 $28.74   108.77%
09/10/2026 Jefferies Amin Makarem $56.00 $45.00   24.44%
08/06/2026 Guggenheim Michael Schmidt $58.00 $46.43   24.92%
07/16/2026 Oppenheimer Leland Gershell $50.00 $39.80   25.63%
05/11/2026 H.C. Wainwright Raghuram Selvaraju $45.00 $29.40   53.06%
04/09/2026 Jefferies Amin Makarem $40.00 $20.53   94.84%
06/13/2025 Goldman Sachs Paul Choi $16.00 $12.03   33%
06/13/2025 Oppenheimer Leland Gershell $31.00 $12.03   157.69%
10/14/2024 EF Hutton Jason Kolbert $25.00 $12.60   98.41%
06/14/2024 Evercore ISI Stephen Richardson $46.00 $20.26   127.05%
06/14/2024 Oppenheimer Leland Gershell $40.00 $17.50   128.57%
06/14/2024 H.C. Wainwright Raghuram Selvaraju $60.00 $17.50   242.86%
06/14/2024 Goldman Sachs Paul Choi $22.00 $17.50   25.71%
05/14/2024 Oppenheimer Leland Gershell $32.00 $13.07   144.84%
03/15/2024 Oppenheimer Leland Gershell $34.00 $14.46   135.13%

UroGen Pharma Ltd FAQ's

UroGen Pharma Ltd has been rated by research analysts at Oppenheimer, Jefferies, Guggenheim, H.C. Wainwright, Goldman Sachs, EF Hutton in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.